Novartis' Daniel Vasella - CEO Pay

Daniel Vasella, Novartis CEO

Daniel Vasella- Novartis

Total Compensation: $15.5M

2006 Revenue: $38.1B
2007 Revenue: $39.8B
Change: 4.46%

Details: Vasella earned 17 million Swiss francs, or about $15.5M in 2007. That's down from 21 million francs in 2006, or $17.5 million -- a figure that some say places him among the highest-paid executives in Europe.

Novartis News:
Vasella touts Novartis' diversification
CEO: Novartis plans big restructuring
Cash-rich Novartis CEO mulls biotech buyouts

Novartis' Daniel Vasella - CEO Pay
Read more on

Suggested Articles

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.